Atreca, Inc. Research and Development (R&D) Expenses Growth

Research and Development (R&D) Expenses Growth of BCEL for past 10 years: annual, quarterly and twelve month trailing (TTM) including Research and Development (R&D) Expenses Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Research and Development (R&D) Expenses Growth for the quarter ending September 30, 2022 was -14.29% (a -396.47% decrease compared to previous quarter)
  • Year-over-year quarterly Research and Development (R&D) Expenses Growth decreased by -144.94%
  • Annual Research and Development (R&D) Expenses Growth for 2021 was 26.28% (a 96.56% increase from previous year)
  • Annual Research and Development (R&D) Expenses Growth for 2020 was 13.37% (a -80.43% decrease from previous year)
  • Annual Research and Development (R&D) Expenses Growth for 2019 was 68.32% (a 82.82% increase from previous year)
  • Twelve month Research and Development (R&D) Expenses Growth ending September 30, 2022 was 3.12% (a -67.7% decrease compared to previous quarter)
  • Twelve month trailing Research and Development (R&D) Expenses Growth decreased by -88.13% year-over-year
Trailing Research and Development (R&D) Expenses Growth for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
3.12% 9.66% 16.31% 26.28%
Visit stockrow.com/BCEL for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Research and Development (R&D) Expenses Growth of Atreca, Inc.

Most recent Research and Development (R&D) Expenses Growthof BCEL including historical data for past 10 years.

Interactive Chart of Research and Development (R&D) Expenses Growth of Atreca, Inc.

Atreca, Inc. Research and Development (R&D) Expenses Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -14.29% 4.82% -7.2%
2021 31.8% 11.38% 34.25% 29.4% 26.28%
2020 17.98% 31.19% -10.94% 21.32% 13.37%
2019 82.6% 72.69% 12.28% -17.57% 68.32%
2018 -45.23% -42.09% 37.37%
2017 -23.91%

Business Profile of Atreca, Inc.

Sector: Healthcare
Industry: Biotechnology